Drilldown: Medicines
Use the filters below to narrow your results.
generic:
brand:
None (78) ·
(none, never marketed) (1) ·
Dalmane (1) ·
Delysid (historical, Sandoz, withdrawn 1965) (1) ·
Doral (1) ·
Doriden (1) ·
Halcion (1) ·
Hetlioz (1) ·
Imovane (1) ·
Lunesta (1) ·
Mogadon (1) ·
Nembutal (1) ·
Placidyl (1) ·
ProSom (1) ·
Quaalude (1) ·
Restoril (1) ·
Rexulti (1) ·
Rohypnol (1) ·
Rozerem (1) ·
Seconal (1) ·
Sonata (1) ·
THIP (1) ·
Versed (1) ·
Xyrem (1)
classes: (Click arrow to add another value)
mechanism:
5-HT2A agonist (26) ·
GABAA positive allosteric modulator (15) ·
Potent 5-HT2A agonist (5) ·
LSD analogue; 5-HT2A agonist (4) ·
Prodrug of LSD; 5-HT2A agonist (4) ·
GABAA positive allosteric modulator (non-benzodiazepine) (3) ·
None (2) ·
Contains LSA (2) ·
Contains mescaline (2) ·
GABAA potentiator and direct activator (2) ·
Melatonin receptor agonist (2)
uses:
None (99) ·
No approved medical problem. Encountered as a designer/research benzodiazepine and, increasingly, as an adulterant in illicit opioid supplies. (1) ·
Schizophrenia (FDA-approved 2015). Adjunctive treatment of major depressive disorder (2015). '''Agitation associated with dementia due to Alzheimer disease''' (FDA-approved May 2023, first agent specifically approved for this problem). Investigational for PTSD (combined with sertraline). (1)
starting dose:
None (99) ·
No medical dose. Active recreational doses reported in the 0.5–1.5 mg range (similar potency to alprazolam). (1) ·
Schizophrenia: 1 mg PO daily × 4 days, then 2 mg daily × 3 days, then 4 mg daily. MDD adjunct: 0.5-1 mg daily, increase to 2 mg max. AD agitation: 0.5 mg daily, titrate to 2-3 mg daily. (1)
preparations:
fda max:
onset:
duration:
halflife:
bioavailability:
pregnancy:
legal:
Showing below up to 101 results in range #1 to #101.